AGI-5198

Inquiry

Cat. No.: DIA-0231318

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	1355326-35-0
Synonyms	IDH-C35
Formula	C₂₇H₃₁FN₄O₂
Molecular Weight	462.56
SMILES	CC1=C(C=CC=C1)C(N(C(=O)C[N]2C=CN=C2C)C3=CC(=CC=C3)F)C(=O)NC4CCCCC4
Product Description	AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.

Format & Storage
Purity	> 97%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Top